Financials data is unavailable for this security.
View more
SmartText is unavailable
| Gross margin | 34.87% |
|---|---|
| Net profit margin | 16.81% |
| Operating margin | 19.86% |
| Return on assets | 13.02% |
|---|---|
| Return on equity | 17.78% |
| Return on investment | 15.16% |
More ▼
Cash flow in USDView more
In 2023, West Pharmaceutical Services Inc did not generate a significant amount of cash. However, the company earned 776.50m from its operations for a Cash Flow Margin of 26.32%. In addition the company used 368.70m on investing activities and also paid 459.60m in financing cash flows.
| Cash flow per share | 8.57 |
|---|---|
| Price/Cash flow per share | 37.01 |
| Book value per share | 37.96 |
|---|---|
| Tangible book value per share | 36.29 |
More ▼
Balance sheet in USDView more
| Current ratio | 3.00 |
|---|---|
| Quick ratio | 2.23 |
| Total debt/total equity | 0.0747 |
|---|---|
| Total debt/total capital | 0.0695 |
More ▼
Growth rates in USD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 5.48% and 2.95%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is above the industry average.
| Div yield(5 year avg) | 0.23% |
|---|---|
| Div growth rate (5 year) | 6.20% |
| Payout ratio (TTM) | 8.95% |
| EPS growth(5 years) | 23.79 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -8.55 |
More ▼
